Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What can we achieve by implementing a compliance-improvement program?

J M Kane1

  • 1Department of Psychiatry, Hillside Hospital, Glen Oaks, New York, USA.

International Clinical Psychopharmacology
|February 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Society, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, London, Ont. Sept. 15-18, 2011.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

How and when to use clozapine.

Acta psychiatrica Scandinavica·2019
Same author

Detecting relapse in youth with psychotic disorders utilizing patient-generated and patient-contributed digital data from Facebook.

NPJ schizophrenia·2019
Same author

Clozapine as an early-stage treatment.

Acta psychiatrica Scandinavica·2018
Same author

Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia.

Acta psychiatrica Scandinavica·2018
Same author

Abnormalities of gait caused by ankle arthritis are improved by ankle arthrodesis.

The bone & joint journal·2016
Same journal

Critical reassessment of manic and psychotic episodes related to levetiracetam: a systematic review of published case reports.

International clinical psychopharmacology·2026
Same journal

Expanding the horizon of brexpiprazole augmentation in treatment-resistant disorders: from obsessive-compulsive disorder to adolescent bipolar disorder.

International clinical psychopharmacology·2026
Same journal

Acceptability-adjusted speed in psychotic agitation: interpreting pro re nata antipsychotic data in real-world care (commentary on Hatta et al.).

International clinical psychopharmacology·2026
Same journal

Antipsychotics in clinical practice: agitation, polypharmacy, and treatment resistance.

International clinical psychopharmacology·2026
Same journal

Methylphenidate treatment in adults with comorbid attention-deficit/hyperactivity disorder and borderline personality disorder: a prospective longitudinal study.

International clinical psychopharmacology·2026
Same journal

Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD).

International clinical psychopharmacology·2026
See all related articles

Improving patient compliance with relapse prevention strategies is crucial. Educating patients, families, and healthcare professionals on disease management and treatment is key to better outcomes and healthcare resource conservation.

Area of Science:

  • Health Services Research
  • Public Health
  • Patient Adherence

Background:

  • Relapse prevention strategies significantly impact millions globally.
  • Improving compliance conserves healthcare resources.

Purpose of the Study:

  • To highlight the critical need for comprehensive education in relapse prevention.
  • To emphasize the importance of educating diverse stakeholders for improved patient outcomes.

Main Methods:

  • Literature review on relapse prevention and patient education.
  • Analysis of stakeholder roles in treatment adherence.
  • Synthesis of current challenges in healthcare resource allocation for chronic diseases.

Main Results:

  • Education for patients and families on disease nature and treatment is vital.

Related Experiment Videos

  • Healthcare professional education on treatment indications, benefits, and risks is essential.
  • Public and administrator education on resource allocation is imperative.

    • Conclusions:

    • Multifaceted educational initiatives are critical for enhancing relapse prevention.
    • Informed patients, families, and professionals lead to better disease management.
    • Strategic resource allocation, driven by informed administrators, supports long-term treatment success.